CERT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

7.390

Open

7.230

VWAP

7.21

Vol

4.07M

Mkt Cap

1.12B

Low

7.055

Amount

29.29M

EV/EBITDA(TTM)

12.76

Total Shares

155.56M

1.25B

EV/OCF(TTM)

13.81

P/S(TTM)

2.71

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.

Events Timeline

(ET)

2026-07-07

08:30:00

Certara Partners with Nvidia to Advance AI Platform

2026-06-17 (ET)

2026-06-17

17:00:00

Certara CFO John Gallagher Announces Resignation

2026-05-11 (ET)

2026-05-11

16:30:00

Major Averages Close Slightly Higher as Investors Focus on Economic Data

News

8.5

07-06PRnewswire

MindWalk Files European Patent for Biological Data Architecture Underpinning AI Drug Discovery

8.5

07-06Newsfilter

MindWalk Files European Patent for Biological Data Architecture Underpinning AI Drug Discovery

7.0

06-25PRnewswire

Certara Under Investigation for Securities Fraud Claims

7.0

06-19Globenewswire

Investigation Launched into Certara by Law Firm for Investor Claims

7.0

06-18Globenewswire

Investigation into Certara Investor Losses Announced

5.0

06-18NASDAQ.COM

Certara CFO John Gallagher to Resign in 2026

11 Analyst Rating

Wall Street analysts forecast CERT stock price to rise

7 Buy

4 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

9.00

Averages

12.11

High

16.00

Current: 0.000

Low

9.00

Averages

12.11

High

16.00

Leerink

Outperform

maintain

AI Analysis

2026-06-16

Reason

Leerink

Price Target

AI Analysis

2026-06-16

maintain

Outperform

Reason

Leerink sees Certara's (CERT) valuation as overly depressed given what remains a highly profitable entity with multiple long-term growth drivers. This morning's acquisition of peer Simulations Plus (SLP) represents a roughly 90% premium to Leerink's current 2027 EV/EBITDA valuation for Certara. The firm thinks that, as the company moves through its investment period under new leadership, the opportunities to expand its model-informed drug discovery push should get the company back to steadier revenue growth, on top of healthy 30%-plus EBITDA margins. Today's news simply provides another context for private market valuation in the space, which is obviously well above where Certara is currently trading, Leerink argues, reiterating an Outperform rating on the stock.

Craig-Hallum

Hold

downgrade

$10 -> $8

2026-05-12

Reason

Craig-Hallum

Price Target

$10 -> $8

2026-05-12

downgrade

Hold

Reason

Craig-Hallum lowered the firm's price target on Certara to $8 from $10 and keeps a Hold rating on the shares. The firm notes the company reported a soft quarter and offered little support that they can return to historic growth rates over the near-term. Company specific issues in services were the reason for the disappointing Q1 results and while steps are being taken to improve execution, it will take some time before material impact is seen, Craig-Hallum adds.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CERT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Certara Inc (CERT.O) is 12.67, compared to its 5-year average forward P/E of 36.83. For a more detailed relative valuation and DCF analysis to assess Certara Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

36.83

Current PE

12.67

Overvalued PE

58.42

Undervalued PE

15.24

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

21.44

Current EV/EBITDA

13.81

Overvalued EV/EBITDA

30.91

Undervalued EV/EBITDA

11.98

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

7.09

Current PS

2.73

Overvalued PS

10.84

Undervalued PS

3.35

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

what should I invest in right now with 400$ ?

Intellectia · 378 candidates

Revenue Ttm: >= 0Price: <= $400.00Volume: >= 500,000Quarter Revenue Yoy Growth: >= 0.0%Analyst Consensus: Strong Buy, Moderate BuyBeta: LowRisk, ModerateRiskMoving Average Relationship: PriceAboveMA20Free Cash Flow Ttm: >= 0

Ticker

Name

Market Cap$

CRON

Cronos Group Inc

1.04B

CURI

CuriosityStream Inc

157.71M

BBD

Banco Bradesco SA

36.68B

PLTK

Playtika Holding Corp

1.42B

NABL

N-Able Inc

691.35M

VTEX

681.94M

can u run the screener and give me list

Intellectia · 19 candidates

Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Is Optionable: TrueOne Month Rise Prob: >= 50One Month Predict Return: >= 0.0%Macd: positive

Ticker

Name

Market Cap$

BKKT

Bakkt Inc

471.49M

VUZI

Vuzix Corp

258.62M

MNDY

monday.com Ltd

3.69B

KYIV

Kyivstar Group Ltd

3.07B

EOSE

Eos Energy Enterprises Inc

2.72B

KOPN

Kopin Corp

992.00M

Whales Holding CERT

Deerfield Management Company, L.P.

ArrowMark Colorado Holdings, LLC

Dixon Mitchell Investment Counsel, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Certara Inc (CERT) stock price today?

The current price of CERT is 7.17 USD — it has increased 0.56

What is Certara Inc (CERT)'s business?

What is the price predicton of CERT Stock?

Wall Street analysts forecast CERT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CERT is12.11 USD with a low forecast of 9.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.